DCI
Data Collective IV Portfolio holdings
AUM
$130M
This Quarter Return
+16.48%
1 Year Return
+250.71%
3 Year Return
+278.3%
5 Year Return
–
10 Year Return
–
AUM
$121M
AUM Growth
+$121M
(+14%)
Cap. Flow
+$9
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
2
Reduced
–
Closed
–
Top Buys
| 1 |
Evolv Technologies
EVLV
|
$5 |
| 2 |
MindMed
MNMD
|
$4 |
Top Sells
No sells this quarter
Sector Composition
| 1 | Industrials | 51.2% |
| 2 | Healthcare | 48.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Recursion Pharmaceuticals
RXRX
$2.02B
| $58.6M | 48.46% |
5,941,120
| – | – |
|
|
2
Evolv Technologies
EVLV
$1.37B
| $45.7M | 37.8% |
9,681,281
+1
| +0% | +$5 |
|
3
Rocket Lab Corporation Common Stock
RKLB
$21B
| $16.2M | 13.4% |
2,929,350
| – | – |
|
|
4
MindMed
MNMD
$689M
| $367K | 0.3% |
100,350
+1
| +0% | +$4 |
|
5
Roivant Sciences
ROIV
$8.6B
| $43.5K | 0.04% |
3,875
| – | – |
|